• Go to navigation
  • Go to content
AstraZeneca Clinical Trials

Astrazeneca Worldwide

  • AstraZeneca Websites
AstraZeneca US

Main navigation

  • Home
  • Therapy Areas
    • Oncology/Infection
    • Cardiovascular
    • Gastrointestinal
    • Neuroscience
    • Respiratory/Inflammation
  • Drug Products
    • All Drug Products
  • Diseases & Conditions
    • All Diseases and Conditions
  • Glossary
  • Contact Us
  • Disclosure Commitment

You are here

  • Home
  • Total number of clinical trials
  • European study in patients with osteoarthritis, rheumatoid arthritis, or ankylosing spondylitis at gastrointestinal risk: A restrospective, non-internventional study of Vimovo™ prescribing patterns.

Disease
prescribing information
Drug Name
non drug study (neuroscience)
Generic Name
VIMOVO
Sponsor
AstraZeneca
Drug Status
Approved Medicine
Phase
Non-Interventional Study
Start Date
Jan 23, 2012
Study Name
CHARACTERIZE
Study Id
D1120C00044
ClinicalTrials.gov ID
NCT01511926
Recruiting Status
Enrolling by invitation
Protocol Status
Not Available
Report Status
Not Available

Page tools

  • Print
  • Bookmark this page

Legal notices

  • Legal notice
  • Privacy policy
  • © AstraZeneca 2013